By Rebecca McAvoy
It will come as a surprise to no one that site start up is a challenging part of the clinical trial process. Various pieces of research on this topic have put the length of site start up (site selection through activation) in the ballpark of 7 to 10 months. In the pharma world, with patent cliffs and competitor products looming, each day is valuable and every delay is costly. To be sure, delays can occur in any step of the site start up process. However, research tells us that the most problematic step of site start up is site contract and budget negotiations…by a mile.